MGTX
NASDAQ
$12.21
MeiraGTx Holdings plc (MGTX)
MeiraGTx Holdings plc, a clinical-stage gene therapy company, focused on developing treatments for patients living with serious illnesses. The company is headquartered in New York, New York.
Sector:
Healthcare
Industry:
Biotechnology
Strong Buy
Target: $28.38 (+132.43%)
Market Cap
$1.02B
Revenue 5Y CAGR
+37.98%
Free Cash Flow Yield
0.41%
Beta (5Y)
1.29
Price Chart
Valuation
Market Cap$1.02B
Forward P/E1.61
P/S14.58
P/B228.30
Profitability
Total Revenue (TTM)$80M
Gross Profit (TTM)$76M
EBITDA-$93M
Profit Margin-151.1%
Operating Margin-13931%
EPS-$1.49
Financial Health
Free Cash Flow Yield0.41%
Growth & Risk
EPS 5Y CAGR-1.60%
Revenue 5Y CAGR+37.98%
Beta (5Y)1.29
Sharpe Ratio0.82